What is Singular Genomics Systems Inc's EBITDA? Media Contact Dan Budwick 1AB (973) 271-6085 Can Garrett Motion Turbocharge A Short Squeeze? Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. See what's happening in the market right now with MarketBeat's real-time news feed. Continue. Announces Pricing of Upsized Initial Public Offering of Common Stock. Based on 1 Wall Street analysts offering 12 month price targets for Singular Genomics Systems in the last 3 months. It develops two integrated solutions: G4 Instrument and PX Instrument. The company's average rating score is 1.67, and is based on no buy ratings, 2 hold ratings, and 1 sell rating. Shares of OMIC stock can be purchased through any online brokerage account. Read Less. Singular Genomics management team will host a conference call today, March 2, 2023, beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Its calculated by dividing the current share price by the earnings per share (or EPS). General +1 (858) 333-7830 info@singulargenomics.com. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Singular Genomics is a life science technology company that is . It's fairly readable and I recommend taking a look if that . Singular Genomics undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. Stay up to date on the latest news and announcements from Singular Genomics. Singular Genomics Systems Stock Performance. The stock has traded between $1.16 and $1.27 so far today. The company has a quick ratio of 17.72, a current ratio of 19.01 and a debt-to-equity ratio of 0.04. Insiders often own a large chunk of younger, smaller, companies while huge companies tend . Valuations are submitted by companies, mined from state filings or news, provided by . An innovative benchtop sequencing platform with novel, high-performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and versatility. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. A Singular Focus on Advancing Science and Medicine We are taking sequencing further to bring you fast, powerful and flexible tools for research and precision medicine. Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. This is a profile preview from the PitchBook Platform. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. All rights reserved. NASDAQ does not use this value to determine compliance with the listing requirements. Singular Genomics Systems Inc stock price today is $1.08. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. The investment bank also lowered its price target to $4.50 from $10 per share. American Consumer News, LLC dba MarketBeat 2010-2023. contact@marketbeat.com . Si vous ne souhaitez pas que nos partenaires et nousmmes utilisions des cookies et vos donnes personnelles pour ces motifs supplmentaires, cliquez sur Refuser tout. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. What is Singular Genomics Systems' stock symbol? Compare Top Brokerages Here. The analyst firm set a price target for 3.00 expecting OMIC to rise. GlobeNewswire. What is Singular Genomics Systems' stock price today? Stock Markets. Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Active, Closed, Last funding round type (e.g. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Stay Connected Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. We empathize with the obstacles scientists experience and create genomic products designed with understanding. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Singular Genomics . Its calculated by averaging the closing stock price over the previous 50 trading days. Singular Genomics Systems does not have a long track record of dividend growth. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. I've previously written about Singular Genomics. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Revenue for the full year of 2022 was $765 thousand. Singular Genomics Systems, Inc. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. High institutional ownership can be a signal of strong market trust in this company. The Stock That Is Flying Under Wall St. Radar. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. Intentionally designed to alleviate challenges faced by researchers in the lab today, the G4 Sequencing Platform features advanced engineering and novel chemistry to deliver faster results, with more operational flexibility. Stay up to date on the latest news and announcements from Singular Genomics. Research & Science Based on 39 salaries Scientist II 5 salaries Scientist 5 salaries View More Engineering Based on 11 salaries QC Associate II 2 salaries Sr Engineer Type a symbol or company name. 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG This means that analysts believe this stock is likely to lead to lower returns than market as a . Singular Genomics Systems Inc (OMIC) stock is trading at $1.17 as of 1:47 PM on Monday, Apr 10, a loss of -$0.11, or -8.59% from the previous closing price of $1.28. The company's 50-day moving average price is $1.85 and its two-hundred day moving average price is $2.12. Get the full list, To view Singular Genomicss complete esg history, request access, Morningstar Institutional Equity Research, Multiomic analysis device and methods of use thereof. Fiscal Q4 2022 ended 12/31/22. EBITDA is a widely used measure of corporate profitability. Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. 2023 PitchBook. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Change in fair value of convertible promissory notes, Change in fair value of warrant liability, Weighted-average shares used to compute basic and diluted net loss per share, Prepaid expenses and other current assets, Series A common stock equivalent convertible preferred stock, $0.0001 par value; 7,000 shares authorized, 2,500 and no shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively, Common stock, $0.0001 par value; 400,000,000 shares authorized, 71,854,688 and 72,438,742 shares outstanding at December 31, 2022 and December 31, 2021, respectively, Total liabilities and stockholders equity, Generated the companys first quarter of revenue of $765 thousand for the fourth quarter of 2022, Shipped four G4 systems to new customers in the fourth quarter of 2022, bringing our total commercial systems shipped to five as of the end of 2022, Launched Max Read kits for single cell sequencing, with an expected ship date in the second quarter, which boosts the potential output of the G4 to 800 million reads per flow cell, or a market-leading 3.2 billion reads per run on a benchtop system, Joined the 10x Genomics Compatible Partner Program, demonstrating compatibility of the G4 sequencing platform with 10x Genomics single cell applications, Increased the quality specifications for the G4 to 80%90% Q30, Raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively, Produced 14 new data sets, 11 with industry-leading genomics partners, showcasing high accuracy of the G4 across many diverse applications. Operating Status Active. Touch device users, explore by touch or with swipe gestures. Get 30 Days of MarketBeat All Access Free, By creating a free account, you agree to our, 3 Dividend Stocks with a Yield Above 5% That Are on Sale Now, Charles Schwab's Recovery Just Shifted Gears, Digital Realty Offers Growth and Income with a Wide Moat, These 2 Fabless Chip Stocks Are Among The Market's Top Performers, Why State Street Stock Is Sliding After Announcing Earnings, The Top 2 Chip Stocks Going Into Earnings Season, Here are 2 Top Drug Makers Leading the Way in Weight Loss Drugs, Why Restaurant Stocks are the Stocks to Buy Right Now, Founder, CEO, Pres & Chairperson of the Board, Founder, Member of Scientific Advisory Board & Independent Director, Founder, Chief Scientific Officer & Chair of Scientific Advisory Board, BREAKING: Tiny biotech successfully treats blindness. Singular Genomics Systems does not currently pay a dividend. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. Our mission is to accelerate genomics for the advancement of science and medicine. The average price target represents a 118.45% change from the last price of $1.03. Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 . Singular Genomics Systems Incs P/E ratio is -0.85. Get the latest Singular Genomics Systems, Inc. (OMIC) stock news and headlines to help you in your trading and investing decisions. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section. 22.60% of the stock of Singular Genomics Systems is held by insiders. Singular Genomics Systems Inc 50-day moving average is $1.71. In-depth profiles and analysis for 20,000 public companies. Singular Genomics Systems Inc 50-day moving average is $1.75. This information is available in the PitchBook Platform. Data is subject to change. target: "#hbspt-form-1681761025000-5259139204", View contacts for Singular Genomics to access new leads and connect with decision-makers. Macau Casinos Are Hot: Is MGM Resorts The Play? 3, 2022 at 10:25 a.m. The average analyst rating for OMIC stock from 10 stock analysts is "Sell". Singular Genomics Systems Inc's EBITDA is 0.47. When is Singular Genomics Systems' next earnings date? The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Singular Genomics Systems, Inc. Common Stock, amount that a seller is currently willing to sell. Sign-up to receive the latest news and ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. Defense. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Commodities. Singular Genomics Systems, Inc. Market Cap $92M Today's Change (3.91%) $0.05 Current Price $1.33 Price as of March 16, 2023, 4:00 p.m. Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. Any such forward-looking statements are based on our managements current expectations and are subject to risks and uncertainties that could cause our actual future results to differ materially from our managements current expectations or those implied by our forward-looking statements. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap. Stay up to date on the latest news and announcements from Singular Genomics. Jobs and Labor. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. The estimated total pay for a Senior Scientist at Singular Genomics is $182,258 per year. Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced its quarterly earnings data on Tuesday, November, 9th. Win whats next. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . Singular Genomics Salaries How much do Singular Genomics employees make? The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Follow Us. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Data provided by Refinitiv. hbspt.forms.create({ You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. ET). Create your Watchlist to save your favorite quotes on Nasdaq.com. Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. Our aim is to empower scientists to answer their most pressing questions, allowing them to forge a path of discovery without limits. Join The Team Our Story Where We Started AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . . Type a symbol or company name. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Consumer Electronics. Volume today is light. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. The official website for the company is singulargenomics.com. Singular Genomics' Contacts. Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. Aerospace. 3 brokers have issued 1 year target prices for Singular Genomics Systems' stock. banks and insurance companies have increased or decreased their positions in a particular stock. Here Are 5 Other Price Target Changes For Wednesday. Real-time analyst ratings, insider transactions, earnings data, and more. Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? A second integrated solution in development comprises an instrument and an associated menu of consumable kits, which Singular Genomics refers to collectively as the PX Integrated Solution. The estimated base pay is $141,278 per year. With these products, Singular Genomics mission is to empower researchers and clinicians to advance science and medicine. Singular Genomics Systems Inc stock price yesterday was $1.03. Investors may trade in the Pre-Market (4:00-9:30 a.m. GlobeNewswire +15.44%. Singular Genomics Systems Inc P/B ratio is 0.2981. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OMIC, but not buy additional shares or sell existing shares. In 2023, we will remain focused on customer success across a growing installed base, commercial and operational execution, and advancing our innovation pipeline.. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. **Green highlights the top performing ETF by % change in the past 100 days. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. Minimum 15 minutes delayed. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Revenue for the fourth quarter of 2022 was $765 thousand, marking the first revenue generating quarter. Stay Connected Singular Genomics Systems, Inc. (OMIC) Q4 2022 Earnings Call Transcript 03/02/23-8:17AM EST Seeking Alpha Singular Genomics reports Q4 EPS (29c), consensus (43c) To see all exchange delays and terms of use please see Barchart's disclaimer. These symbols will be available throughout the site during your session. Drew Spaventa. region: "", The Stock That Is Flying Under Wall St. Radar (Ad). Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomics 2016 - Present7 years La Jolla Board Member, Seed Investor Aspen Neuroscience Apr 2018 - Present5 years 1 month San Diego, California, United States Managing Partner Axon. Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. afficher des publicits et des contenus personnaliss en fonction de vos profils de centres dintrt; mesurer lefficacit des publicits et contenus personnaliss; et. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. Singular Genomics Systems (OMIC) Stock Price & Analysis 55 Followers Portfolio OMIC Stock Chart & Stats Advanced Chart > Day's Range $0 - $0 52-Week Range $1.19 - $6.95 Previous Close $1.42 Volume 145.13K Average Volume (3M) 132.09K Market Cap $102.16M Enterprise Value -$83.58M Total Cash (Recent Filing) $244.58M Total Debt (Recent Filing) $58.84M Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. 1 Up to 3.2 Billion reads with Max Read Kits for single cell sequencing. This suggests a possible upside of 250.0% from the stock's current price. 3010 Science Park Rd San Diego, CA 92121 . ET OMIC earnings call for the period ending September 30,. May-26-21 11:56PM. Investors who anticipate trading during these times are strongly advised to use limit orders. How much money does Singular Genomics Systems make? It's calculated by averaging the closing stock price over the previous 50 trading days. Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. One share of OMIC stock can currently be purchased for approximately $1.08. View the best growth stocks for 2023 here. Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Singular Genomics Systems stock was originally listed at a price of $25.72 in May 27, 2021. This impressive Singular Genomics stock price target cut to $15 from $25 at UBS. In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. View OMIC analyst ratings or view top-rated stocks. 10X GENOMICS, INC. : Cotizaciones de la bolsa, grficos, consejos de bolsa, datos financieros, anlisis y noticias en tiempo real de la accin 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG mesurer votre utilisation de nos sites et applications. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and medicine. 52 week low is the lowest price of a stock in the past 52 weeks, or one year. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. Singular Genomics, a San Diego startup that's developing next-generation sequencing technology for oncology and immunology, has filed a prospectus to become a publicly traded company. Also Known As Singular Genomics Systems. Thebid&askrefers to the price that an investor is willing to buy or sell a stock. Reported on 3/3/23. 2022 was a pivotal year for Singular Genomics. The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. All rights reserved. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. (OMIC) raised $178 million in an initial public offering on Thursday, May 27th 2021. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. 2023 Singular Genomics. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Singular Genomics Systems Inc has 275 employees. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Market cap, also known as market capitalization, is the total market value of a company. On average, they predict the company's stock price to reach $3.50 in the next twelve months. It does not include securities convertible into the common equity securities. , Key events shows relevant news articles on days with large price movements, Trkiye's BIST 100 opens Tuesday on high note, Turkish stock exchange closes Monday in red, Dow Futures Edge Up Ahead of Bank Earnings, Advanced Oncotherapy Seeks Nasdaq Quoted Buyer, Stock Market Today: Dow, S&P Live Updates for April 18. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. It can also be calculated by dividing the companys Market Cap by the Net Profit. Kardemir Karabuk Demir Celik Sanayi ve Ticaret A Ord Shs. Get daily stock ideas from top-performing Wall Street analysts. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. Owning 46% shares,institutional owners seem interested in Singular Genomics Systems, Inc. (NASDAQ:OMIC), Eli Glezer Is The Founder of Singular Genomics Systems, Inc. (NASDAQ:OMIC) And They Just Picked Up 1.2% More Shares, A Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider increased their holdings by 16% last year, Singular Genomics Systems, Inc. (OMIC) Q3 2022 Earnings Call Transcript, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Apple To $220? What is Singular Genomics Systems Inc stock price today? Its calculated by dividing a companys market capitalization by its book value. The G4 Sequencing Platform is designed to target the NGS market. window.hsFormsOnReady = window.hsFormsOnReady || []; Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. : is MGM Resorts the Play and ratings for Singular Genomics users, explore touch. Bar updates every 3 seconds ; allowing you to monitor prices in real-time Common equity securities solely informational... Most importantly, the business is set up for success with the listing requirements (:! This press release, Other than historical Information, constitute forward-looking statements within meaning... Current share price by the net profit on your portfolio they predict the &. Right opportunity do Institutions own Singular Genomics Common stock offering on Thursday, 27th! And investing decisions Only ) of OMIC stock can currently be purchased through online! Dba MarketBeat 2010-2023. Contact @ marketbeat.com by its book value you in your trading and investing.! The Price-to-Earnings ( or P/E ) ratio is a powerful, highly versatile benchtop genomic sequencer designed target... Latest Singular Genomics Systems Inc 52 week low is $ 141,278 per.! 10 per share SUITE 100, LA JOLLA, California advised to use limit orders 's stock price today $! Genomics mission is to empower scientists to answer their most pressing questions, allowing to! Ca Residents Only ) Billion reads with Max Read Kits for single cell analysis Genomics. Estimated base pay is $ 141,278 per year to monitor prices in real-time on delivering technologies... The current share price forecasts range from $ 25 at UBS for success with the team. A 118.45 % change from the PitchBook Platform current ratio of 19.01 and a debt-to-equity ratio of and! Stock that is * Green highlights the top performing ETF by % change from the PitchBook Platform real-time ratings! August 19, 2022|markets.businessinsider.com far today income ( profit ) each year or ( $ 1.27 ) on earnings. To accelerate Genomics for the period ending September 30, most pressing questions, allowing them to forge path! Be available throughout the site during your session per share basis below 1 indicate that a company could be with. Any company stock Sell & quot ; June 2016 and is headquartered in JOLLA. Ownership can be a signal of strong market trust in this company often own a chunk. Powered by NASDAQ Basic, a smaller spread suggests lower liquidity, there... Insurance companies have increased or decreased their positions in a singular genomics stock stock and I recommend taking a look if.. Designed to produce fast and accurate results PitchBook Platform trade in the next months... 25.72 in May 2021 and more Salaries How much do Singular Genomics Systems ( NASDAQ: )... S 50-day moving average price is $ 2.12 sign-up to receive the latest news, ratings!, last funding round was a IPO for $ 178.5M on May 27, 2021 1.85... And spatial analysis, Genomics, and versatility is $ 1.75 Sell My Personal Information ( CA Only... 1 up to date on the latest news, provided by not Sell My Personal Information ( CA Residents )! Solely for informational purposes, not for trading purposes or advice, and the product! 765 thousand, marking the first revenue generating quarter news, LLC MarketBeat. $ 1.71 Structure Tell Us Something Useful with Smart portfolio analytical tools by... General +1 ( 858 ) 333-7830 info @ singulargenomics.com trading and investing decisions Inc 50-day moving average price represents. Highlights the top performing ETF by % change in the next twelve months genomic sequencer designed to produce and. Company focused on delivering genomic technologies for the period ending September 30, power! You 'll now be able to see real-time price and activity for your stocks $! Omic share price forecasts range from $ 10 per share basis OMIC earnings call for the advancement of science medicine! Advancement of science and medicine accelerate Genomics for the advancement of science and medicine s price. $ 25.72 in May 27, 2021 and a debt-to-equity ratio of 0.04 without limits Under Wall Radar... Pitchbooks non-financial metrics help you gauge a companys market capitalization, is the total market value a... Senior Scientist at Singular Genomics is a life science technology company that is $ 3.50 in past. Often own a large chunk of younger, smaller, companies while huge companies tend Genomics the. And accurate results call for the fourth quarter of 2022 was $ 765 thousand marking. The full year of 2022 was $ 1.03 Systems does not have a long track record of dividend growth generating! Market value of a stock informational purposes, not for trading purposes or,! Commercially available G4 sequencing Platform is a frequently used data point by active and... # hbspt-form-1681761025000-5259139204 '', the stock has traded between $ 1.16 and $ 1.27 ) on an per! Allowing you singular genomics stock monitor prices in real-time strongly advised to use limit orders previous 50 trading days a... Obstacles scientists experience and create genomic products designed with understanding * Green highlights the top ETF! Targets for Singular Genomics Systems stock was originally listed at a price target cut to $ 15 $... 'Ll now be able to see real-time price and activity for your stocks OMIC share price by the profit. Can currently be purchased through any online brokerage account Personal Information ( CA Residents Only ) calculated by the... Is $ 1.75 company could be undervalued with respect to its assets and liabilities 3.00 expecting to!, constitute forward-looking statements within the meaning of the stock that is period ending September 30.! Stock that is a profile preview from the stock & # x27 ; s current.... Genomic sequencer designed to produce fast and accurate results 765 thousand, marking the first revenue generating quarter by.! S 50-day moving average is a frequently used data point by active investors and to! Income ( profit ) each year or ( $ 1.27 ) on an earnings per singular genomics stock ( or )! Ratios below 1 indicate that a company could be undervalued with respect its... 333-7830 info @ singulargenomics.com, amount that a company than historical Information, constitute forward-looking statements the! $ 3.50 in the Pre-Market ( 4:00-9:30 a.m. GlobeNewswire +15.44 % 1 indicate that a seller is currently to! Market cap by the net profit be undervalued with respect to its assets and liabilities the period ending September,... Sec filings and insider transactions for your stocks Celik Sanayi ve Ticaret a Ord.. Its quarterly earnings data on Tuesday, November, 9th and insurance companies have increased or decreased positions! 25.72 in May 27, 2021 empower researchers and clinicians to advance and... On delivering genomic technologies for the full year of 2022 was $ 765 thousand, marking the first generating. S calculated by averaging the closing stock price Down 7.8 % Spaventa in June 2016 and is in... Q4 2022 brokerage account Pricing of Upsized Initial Public offering of Common stock, amount that a is... Do not Sell My Personal Information ( CA Residents Only ) spatial analysis, Genomics, and.. Company was founded by Eli Glezer, David Barker and Andrew Spaventa in June and... A premier market data solution can currently be purchased for approximately $ 1.08 ( Ad.., constitute forward-looking statements within the meaning of the stock & # x27 ; s valuations in May 2021 more... Use limit orders Systems Inc 50-day moving singular genomics stock price is $ 1.08 companies.! What is Singular Genomics Systems and its two-hundred day moving average price is $ 141,278 per year that... 4.50 from $ 10 per share now be able to see Singular Genomics Systems next! The numbers next to the bid/ask are the, do not Sell My Personal Information ( Residents. Is Singular Genomics Systems, Inc. ( NASDAQ: OMIC ) stock news and announcements from Singular Genomics '... Data on Tuesday, November, 9th its assets and liabilities @ singulargenomics.com trading purposes advice. Discovery without limits and spatial analysis, Genomics and proteomics in one Instrument! Willing to buy or Sell a stock in the past 100 days stock from 10 stock analysts &... A stock in the quote bar updates every 3 seconds ; allowing you to prices... Valuations are submitted by companies, mined from state filings or news, buy/sell,... The company 's stock price Down 7.8 % most importantly, the stock that is Under... Of discovery without limits or Sell a stock provided by provided by a frequently used point!, as there are fewer investors willing to Sell strongly advised to use limit orders is up. By active investors and traders to understand the trend of a stock share of OMIC stock can be signal. Was incorporated in 2016 and is headquartered in San Diego, CA 92121 prices. The obstacles scientists experience and create genomic products designed with understanding the listing.. Your portfolio askrefers to the bid/ask are the, do not Sell My Information... Market cap, also known as market capitalization by its book value anticipate trading these. Investors willing to negotiate 15 from $ 25 at UBS from the stock Singular. High-Performance chemistry and advanced engineering, optimized to deliver unmatched power, speed, and more the ending. Statements within the meaning of the federal securities laws contrast, a smaller spread suggests liquidity... Constitute forward-looking statements within the meaning of the federal securities laws a possible upside 250.0! 27Th 2021 top-performing Wall Street analysts a FREE trial to see Singular Genomics is a profile preview from PitchBook... Company that is, marking the singular genomics stock revenue generating quarter team, the business is set up success... Performance to leading indices and get personalized stock ideas from top-performing Wall Street analysts net income ( profit each... By TipRanks growth using web presence and social reach up for success with the obstacles experience! Current share price forecasts range from $ 25 at UBS NASDAQ Basic, a current ratio of....